Metabolic installation of macrophage-recruiting glycan ligand on tumor cell surface for in vivo tumor suppression.
Xie Y, Li Y, Han S.
Synthetic probes that could direct immune cells against tumors are potential immunotherapeutics. We herein report in vivo tumor suppression via an intravenously injected abiotic sialic acid (<sup>TCC</sup>Sia) that could be metabolically incorporated into tumor cell surface to yield of a high affinity ligand (<sup>TCC</sup>Siaα2,3-Gal) of Siglec-1 specifically expressed on macrophages. We observed marked suppression of pulmonary metastasis and subcutaneous tumor growth of B16F10 melanoma cells in mice with <sup>TCC</sup>Sia, suggesting the utility of abiotic sialic acid to modulate tumor immunity via recruiting Siglec<sup>+</sup> immune cells.